JPMorgan Chase & Co’s INmune Bio INMB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $169K | Buy |
73,097
+66,700
| +1,043% | +$154K | ﹤0.01% | 4538 |
|
|
2025
Q1 | $50K | Sell |
6,397
-4,938
| -44% | -$38.6K | ﹤0.01% | 5035 |
|
|
2024
Q4 | $52.9K | Buy |
11,335
+5,461
| +93% | +$25.5K | ﹤0.01% | 4994 |
|
|
2024
Q3 | $31.7K | Buy |
5,874
+672
| +13% | +$3.62K | ﹤0.01% | 5105 |
|
|
2024
Q2 | $45.9K | Buy |
+5,202
| New | +$45.9K | ﹤0.01% | 4929 |
|
|
2024
Q1 | – | Sell |
-3,479
| Closed | -$39.2K | – | 6522 |
|
|
2023
Q4 | $39.2K | Buy |
+3,479
| New | +$39.2K | ﹤0.01% | 5076 |
|
|
2020
Q3 | – | Sell |
-3
| Closed | – | – | 4891 |
|
|
2020
Q2 | $0 | Buy |
+3
| New | – | ﹤0.01% | 4832 |
|